Abstract:Many diseases, as well as side effects of drugs, manifest themselves through skin symptoms. Skin is a complex tissue that hosts various specialized cell types and performs many roles including physical barrier, immune and sensory functions. Therefore, modeling skin in vitro presents technical challenges for tissue engineering. Since the first attempts at engineering human epidermis in 1970s, there has been a growing interest in generating full-thickness skin constructs mimicking physiological functions by incorporating various skin components, such as vasculature and melanocytes for pigmentation. Development of biomimetic in vitro human skin models with these physiological functions provides a new tool for drug discovery, disease modeling, regenerative medicine and basic research for skin biology. This goal, however, has long been delayed by the limited availability of different cell types, the challenges in establishing co-culture conditions, and the ability to recapitulate the 3D anatomy of the skin. Recent breakthroughs in induced pluripotent stem cell (iPSC) technology and microfabrication techniques such as 3D-printing have allowed for building more reliable and complex in vitro skin models for pharmaceutical screening. In this review, we focus on the current developments and prevailing challenges in generating skin constructs with vasculature, skin appendages such as hair follicles, pigmentation, immune response, innervation, and hypodermis. Furthermore, we discuss the promising advances that iPSC technology offers in order to generate in vitro models of genetic skin diseases, such as epidermolysis bullosa and psoriasis. We also discuss how future integration of the next generation human skin constructs onto microfluidic platforms along with other tissues could revolutionize the early stages of drug development by creating reliable evaluation of patient-specific effects of pharmaceutical agents. Impact statement Skin is a complex tissue that hosts various specialized cell types and performs many roles including barrier, immune, and sensory functions. For human-relevant drug testing, there has been a growing interest in building more physiological skin constructs by incorporating different skin components, such as vasculature, appendages, pigment, innervation, and adipose tissue. This paper provides an overview of the strategies to build complex human skin constructs that can faithfully recapitulate human skin and thus can be used in drug development targeting skin diseases. In particular, we discuss recent developments and remaining challenges in incorporating various skin components, availability of iPSC-derived skin cell types and in vitro skin disease models. In addition, we provide insights on the future integration of these complex skin models with other organs on microfluidic platforms as well as potential readout technologies for high-throughput drug screening.

Human skin-on-a-chip for mpox pathogenesis studies and preclinical drug evaluation

The renaissance of human skin organ culture: A critical reappraisal

Skin-on-a-chip technologies towards clinical translation and commercialization

Advances in Skin-on-a-Chip Technologies for Dermatological Disease Modeling

Human mpox: Biology, epidemiology, therapeutic options, and development of small molecule inhibitors

Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions

Mpox (formerly monkeypox): pathogenesis, prevention, and treatment

Microfluidic Skin‐on‐a‐Chip Models: Toward Biomimetic Artificial Skin

Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform

Use of mouse primary epidermal organoids for USA300 infection modeling and drug screening

Analysis of Drug Efficacy for Inflammatory Skin on an Organ-Chip System

Characterization of Human Immortalized Keratinocyte Cells Infected by Monkeypox Virus

3D skin models along with skin-on-a-chip systems: A critical review

Enhancing Diagnostic Accuracy in Common Human Poxvirus Infections During Mpox Outbreak: A Dermoscopy Review

Challenges and promises in modeling dermatologic disorders with bioengineered skin

Next generation human skin constructs as advanced tools for drug development

A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood–Brain Barrier Crossing Therapeutic Strategies

Mpox treatment evolution: past milestones, present advances, and future directions

The Unique Immune Evasion Mechanisms of the Mpox Virus and Their Implication for Developing New Vaccines and Immunotherapies

Progress in the Application of Organoids-On-A-Chip in Diseases

Advancements in Preclinical Human-Relevant Modeling of Pulmonary Vasculature On-Chip